JP2022525040A - 非小細胞肺がんの女性非喫煙者の処置方法 - Google Patents

非小細胞肺がんの女性非喫煙者の処置方法 Download PDF

Info

Publication number
JP2022525040A
JP2022525040A JP2021553070A JP2021553070A JP2022525040A JP 2022525040 A JP2022525040 A JP 2022525040A JP 2021553070 A JP2021553070 A JP 2021553070A JP 2021553070 A JP2021553070 A JP 2021553070A JP 2022525040 A JP2022525040 A JP 2022525040A
Authority
JP
Japan
Prior art keywords
lung cancer
small cell
cell lung
patient
dithio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021553070A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022525040A5 (https=
Inventor
クルカミ、アディッティア
アサイタンビ、アルン
Original Assignee
ランタン ファルマ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ランタン ファルマ インコーポレイテッド filed Critical ランタン ファルマ インコーポレイテッド
Publication of JP2022525040A publication Critical patent/JP2022525040A/ja
Publication of JP2022525040A5 publication Critical patent/JP2022525040A5/ja
Priority to JP2025011556A priority Critical patent/JP2025081338A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
JP2021553070A 2019-03-08 2020-03-08 非小細胞肺がんの女性非喫煙者の処置方法 Pending JP2022525040A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025011556A JP2025081338A (ja) 2019-03-08 2025-01-27 非小細胞肺がんの女性非喫煙者の処置方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962815762P 2019-03-08 2019-03-08
US62/815,762 2019-03-08
PCT/US2020/021615 WO2020185640A1 (en) 2019-03-08 2020-03-08 Method for treating female non-smokers with non-small cell lung cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025011556A Division JP2025081338A (ja) 2019-03-08 2025-01-27 非小細胞肺がんの女性非喫煙者の処置方法

Publications (2)

Publication Number Publication Date
JP2022525040A true JP2022525040A (ja) 2022-05-11
JP2022525040A5 JP2022525040A5 (https=) 2023-03-14

Family

ID=72427123

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021553070A Pending JP2022525040A (ja) 2019-03-08 2020-03-08 非小細胞肺がんの女性非喫煙者の処置方法
JP2025011556A Pending JP2025081338A (ja) 2019-03-08 2025-01-27 非小細胞肺がんの女性非喫煙者の処置方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025011556A Pending JP2025081338A (ja) 2019-03-08 2025-01-27 非小細胞肺がんの女性非喫煙者の処置方法

Country Status (11)

Country Link
US (1) US20220168258A1 (https=)
EP (1) EP3935043A4 (https=)
JP (2) JP2022525040A (https=)
KR (1) KR20220047208A (https=)
CN (2) CN113906010A (https=)
AU (2) AU2020235823A1 (https=)
BR (1) BR112021017716A2 (https=)
CA (1) CA3132827A1 (https=)
MX (1) MX2021010745A (https=)
SG (1) SG11202109705YA (https=)
WO (1) WO2020185640A1 (https=)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011514356A (ja) * 2008-03-14 2011-05-06 バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド 化学的保護方法及び組成物
JP2011514355A (ja) * 2008-03-14 2011-05-06 バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド 肺癌、腺癌及び他の病状のための治療方法及び組成物
JP2011527285A (ja) * 2008-03-14 2011-10-27 バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド 癌患者の生存時間を増大させるための組成物及び化合物の使用方法
US20170007561A1 (en) * 2014-08-08 2017-01-12 Bionumerik Pharmaceuticals, Inc. Contemporaneous, heterogeneously-oriented, multi-targeted therapeutic modification and/or modulation of disease by administration of sulfur-containing, amino acid-specific small molecules

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011514356A (ja) * 2008-03-14 2011-05-06 バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド 化学的保護方法及び組成物
JP2011514355A (ja) * 2008-03-14 2011-05-06 バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド 肺癌、腺癌及び他の病状のための治療方法及び組成物
JP2011527285A (ja) * 2008-03-14 2011-10-27 バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド 癌患者の生存時間を増大させるための組成物及び化合物の使用方法
US20170007561A1 (en) * 2014-08-08 2017-01-12 Bionumerik Pharmaceuticals, Inc. Contemporaneous, heterogeneously-oriented, multi-targeted therapeutic modification and/or modulation of disease by administration of sulfur-containing, amino acid-specific small molecules

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NORIYUKI MASUDA; ET AL: "PHASE I AND PHARMACOLOGIC STUDY OF BNP7787, A NOVEL CHEMOPROTECTOR IN PATIENTS WITH ADVANCED NON-SMA", CANCER CHEMOTHER PHARMACOL(2011), vol. VOL:67, NR:3, JPN5022005715, 15 May 2010 (2010-05-15), pages 533 - 542, ISSN: 0005267265 *

Also Published As

Publication number Publication date
EP3935043A4 (en) 2023-01-11
JP2025081338A (ja) 2025-05-27
BR112021017716A2 (pt) 2021-11-16
MX2021010745A (es) 2021-12-15
US20220168258A1 (en) 2022-06-02
EP3935043A1 (en) 2022-01-12
AU2020235823A1 (en) 2021-11-04
WO2020185640A1 (en) 2020-09-17
AU2025267367A1 (en) 2025-12-04
KR20220047208A (ko) 2022-04-15
CN120078760A (zh) 2025-06-03
SG11202109705YA (en) 2021-10-28
CA3132827A1 (en) 2020-09-17
CN113906010A (zh) 2022-01-07

Similar Documents

Publication Publication Date Title
KR102713072B1 (ko) 두경부암 치료를 위한 egfr 저해제
US20120053211A1 (en) Treatment of pancreatic cancer
Grünwald et al. Managing side effects of angiogenesis inhibitors in renal cell carcinoma
US11890292B2 (en) Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
CN107073015A (zh) 用于治疗吸烟者中的非小细胞肺癌的维利帕尼与卡铂和紫杉醇的组合
CA3134156C (en) Chiauranib for treatment of small cell lung cancer
JP2022525040A (ja) 非小細胞肺がんの女性非喫煙者の処置方法
CN102946880A (zh) 治疗胰腺癌的方法
Tanaka et al. Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003)
US20130090320A1 (en) Method of treating prostate cancer
CN102883720A (zh) 治疗胰腺癌的方法
EP3752154A1 (en) Methods and combination therapy to treat biliary tract cancer
WO2023056063A1 (en) Raf kinase inhibitors for treating tumors harboring gene fusions
Gent et al. An overview of chemotherapy-induced peripheral sensory neuropathy, focusing on oxaliplatin
TW202337897A (zh) 抗ｐｄ－１抗體和抗ｖｅｇｆ－ａ抗體的藥物組合及其使用方法
WO2015171973A9 (en) Pre-selection of subjects for therapeutic treatment with an hsp90 inhibitory compound based on chemosensitive status
JP2013510126A (ja) コリン含有医薬組成物
ES3052187T3 (en) Combination of cisplatin and elimusertib for the treatment of pediatric liver cancers
TW202532061A (zh) 治療非小細胞肺癌(NSCLC)的地美司納(Dimesna)及培美曲塞(Pemetrexed)之組合
JP2026509374A (ja) 腫瘍学的病態および神経障害性疼痛の処置における使用のための２－ヒドロキシ－オクタデセン－９－ｃｉｓ－オエート
Patel et al. Lung cancer: Advances in clinical research
WO2024022282A1 (zh) 吡啶胺化合物在特定ros1基因融合的非小细胞肺癌中的应用
Fonseca et al. 6ER-014 Analysis of the evolution of interleukin-6 in COVID-19 patients after being treated with dexamethasone
US20120309847A1 (en) Dosing regimens and methods for treating or preventing promyelocytic leukemia
TW202610631A (zh) 用於以２，２＇－二硫基雙乙烷磺化物、卡鉑及吡咯葉酸治療非小細胞肺癌的方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230306

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230306

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240222

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240229

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240522

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240722

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240821

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240927